Actions for Medications for opioid use disorder save lives [electronic resource]
Medications for opioid use disorder save lives [electronic resource] / Committee on Medication-Assisted Treatment for Opioid Use Disorders ; Alan I. Leshner and Michelle Mancher, editors ; Board on Health Sciences Policy ; Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
- Corporate Author
- National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Medication-Assisted Treatment for Opioid Use Disorder
- Published
- Washington, DC : The National Academies Press, [2019]
- Physical Description
- xviii, 156 pages : color illustrations, color maps ; 23 cm.
- Additional Creators
- Leshner, Alan I., 1944-, Mancher, Michelle, National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Health Sciences Policy, and National Academies of Sciences, Engineering, and Medicine (U.S.). Health and Medicine Division
Access Online
- Series
- Restrictions on Access
- License restrictions may limit access.
- Contents
- The effectiveness of medication-based treatment for opioid use disorder -- Treatment with medications for opioid use disorder in different populations -- Medications for opioid use disorder in various treatment settings -- Barriers to broader use of medications to treat opioid use disorder.
- Summary
- "The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already exist--like evidence-based medications--are not being deployed to maximum impact"--
- Subject(s)
- Opioid abuse—Treatment—United States
- Drug addicts—Rehabilitation—United States
- Opioids—Overdose—Treatment—United States
- Brain—Diseases—Treatment—United States
- Opioid abuse—Prevention—Government policy
- Methadone maintenance—United States
- Buprenorphine—Therapeutic use—United States
- Naloxone—Therapeutic use—United States
- Naltrexone—Therapeutic use—United States
- Opiate Substitution Treatment
- Opioid-Related Disorders—therapy
- Drug Users
- Drug Overdose
- Genre(s)
- ISBN
- 9780309486484 (paperback)
0309486483 (paperback) - Bibliography Note
- Includes bibliographical references.
View MARC record | catkey: 34549952